Dopamine D-1 regulation of caudate neurotensin mRNA in the presence or absence of the nigrostriatal dopamine pathway

Molecular Brain Research

Volumn 66, Issue 1-2, 1999, Pages 111-121

  Hanson, Glen R ^a   Keefe, Kristen A ^a  

^a UNIVERSITY OF UTAH   (United States)

Author keywords

Caudate nucleus; Dopamine; Extrapyramidal; Neurotensin; Parkinson's disease; Striatum

Indexed keywords

3 ALLYL 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; COMPLEMENTARY DNA; DESIPRAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 1 RECEPTOR STIMULATING AGENT; MESSENGER RNA; NEUROTENSIN; OXIDOPAMINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CAUDATE NUCLEUS; CONTROLLED STUDY; DEGENERATIVE DISEASE; DOPAMINERGIC SYSTEM; EXTRAPYRAMIDAL SYSTEM; GENE EXPRESSION REGULATION; IN SITU HYBRIDIZATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NEUROLOGIC DISEASE; NEUROTRANSMISSION; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA;

ANIMALS; BENZAZEPINES; CAUDATE NUCLEUS; DOPAMINE; DOPAMINE AGONISTS; EXTRAPYRAMIDAL TRACTS; IN SITU HYBRIDIZATION; MALE; NEUROTENSIN; NUCLEUS ACCUMBENS; OXIDOPAMINE; PARKINSON DISEASE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; RNA, MESSENGER; SUBSTANTIA NIGRA; SYMPATHOLYTICS;

EID: 0033586448     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(99)00033-9     Document Type: Article

References (37)

1. Alexander M.J., Miller M.A., Dorsa D.M., Bullock B.P., Melloni R.H., Dobner P.R., Leeman S.E. Distribution of neurotensin neuromedin N mRNA in rat forebrain: unexpected abundance in hippocampus and subiculum. Proc. Natl. Acad. Sci. USA. 86:1989;5202-5206.
2. Berendse H., Groenewegen H.J. Organization of the thalamostriatal projections in the rat, with special emphasis on the ventral striatum. J. Comp. Neurol. 299:1990;187-228.
3. Betancur C., Rostene W., Berod A. Chronic cocaine increases neurotensin gene expression in the shell of the nucleus accumbens and in discrete regions of the striatum. Mol. Brain Res. 44:1997;334-340.
4. Brog J.S., Zahm D.S. Morphology and Fos immunoreactivity reveal two subpopulations of striatal neurotensin neurons following acute 6-hydroxydopamine lesions and reserpine administration. Neuroscience. 65:1995;71-86.
5. Castel M., Morino P., Nylander I., Terenius L., Hokfelt T. Immunohistochemical evidence for a neurotensin striatonigral pathway in the rat brain. Neuroscience. 55:1993;833-847.
6. Castel M., Morino P., Frey L., Terenius L., Hokfelt T. Differential dopaminergic regulation of the neurotensin striatonigral and striatopallidal pathways in the rat. Eur. J. Neurosci. 262:1994;1-10.
7. Castel M., Morino P., Dagerlind A., Hokfelt T. Up-regulation of neurotensin mRNA in the rat striatum after acute methamphetamine treatment. Eur. J. Neurosci. 6:1994;646-656.
8. Ervin G.N., Birkemo L.S., Nemeroff C.B., Prange A.J. Neurotensin blocks certain amphetamine-induced behaviors. Nature. 291:1981;73-76.
9. Gerfen C.R., Engber T.M., Mahan L.C., Susel Z., Chase T.N., Monsma R.J. Jr., Sibley S.D. D-1 and D-2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science. 250:1990;1429-1432.
10. Govoni S., Hong J.S., Yang H.Y-T., Costa E. Increase of neurotensin content elicited by neuroleptics in the nucleus accumbens. J. Pharmacol. Exp. Ther. 215:1980;413-417.
11. Grima B., Lamouroux A., Blanot F., Biguet N.F., Mallet J. Complete coding sequence of rat tyrosine hydroxylase mRNA. Proc. Natl. Acad. Sci. USA. 82:1985;617-621.
12. Hanson G.R., Singh N., Merchant K., Johnson M., Bush L., Gibb J.W. Responses of limbic and extrapyramidal neurotensin systems to stimulants of abuse: involvement of dopaminergic mechanisms. Ann. New York Acad. Sci. 668:1992;165-172.
13. Hanson G.R., Smiley P., Johnson M., Letter A., Bush L., Gibb J.W. Response by the neurotensin systems of the basal ganglia to cocaine treatment. Eur. J. Pharmacol. 160:1989;23-30.
14. Kilts C.D., Anderson C.M., Bissette G., Ely T.D., Nemeroff C.B. Differential effects of antipsychotic drugs on the neurotensin concentration of discrete rat brain nuclei. Biochem. Pharmacol. 37:1988;1547-1554.
15. Kitabgi P. Commentary, neurotensin modulates dopamine neurotransmission at several levels along brain dopaminergic pathways. Neurochem. Int. 14:1989;111-119.
16. LeMoine C., Block B. D-1 and D-2 dopamine receptor gene expression in the rat striatum: sensitive cRNA probes demonstrate prominent segregation of D-1 and D-2 mRNA in distinct neuronal population of the dorsal and ventral striatum. J. Comp. Neurol. 355:1995;418-426.
17. Letter A., Merchant K.M., Gibb J.W., Hanson G.R. Effect of methamphetamine on neurotensin concentrations in rat brain regions. J. Pharmacol. Exp. Ther. 241:1987;443-447.
18. Masuo Y., Pelaprat D., Montague M., Scherman D., Rostene W. Regulation of neurotensin-containing neurons in the rat striatum and substantia nigra. Effects of unilateral lesion with 6-hydroxydopamine on neurotensin content and its binding intensity. Brain Res. 510:1990;203-210.
19. Merchant K.M., Bush L.G., Gibb J.W., Hanson G.R. Dopamine D-2 receptors exert tonic regulation over discrete neurotensin systems. Brain Res. 500:1989;21-29.
20. Merchant K.M., Gibb J.W., Hanson G.R. Role of dopamine D-1 and D-2 receptors in the regulation of neurotensin systems of the neostriatum and the nucleus accumbens. Eur. J. Pharmacol. 160:1989;409-412.
21. Merchant K.M., Miller M.A., Ashleigh E.A., Dorsa D.M. Haloperidol rapidly increases the number of neurotensin mRNA-expressing neurons in neostriatum of the rat brain. Brain Res. 540:1991;311-314.
22. Merchant K.M., Dobner P.R., Dorsa D.M. Differential effects of haloperidol and clozapine on neurotensin gene transcription in rat neostriatum. J. Neurosci. 12:1992;652-663.
23. Merchant K.M., Dorsa D.M. Differential induction of neurotensin and c-fos gene expression induced by typical versus atypical antipsychotics. Proc. Natl. Acad. Sci. USA. 90:1993;3447-3451.
24. Merchant K.M., Hanson G.R., Dorsa D. Induction of neurotensin and c-fos mRNA in distinct subregions of rat neostriatum after acute methamphetamine: comparison with acute haloperidol effects. J. Pharmacol. Exp. Ther. 269:1994;806-812.
25. Merchant K.M. c-Fos antisense oligonucleotide specifically attenuates haloperidol-induced increases in neurotensin/neuromedin N mRNA expression in rat dorsal striatum. Mol. Cell Neurosci. 5:1994;336-344.
26. Nemeroff C., Cain S. Neurotensin-dopamine interactions in the CNS. Trends Pharmacol. Sci. 6:1985;201-205.
27. Nisenbaum L., Crowley W., Kitai S. Partial striatal dopamine depletion differentially affects striatal substance P and enkephalin messenger RNA expression. Mol. Brain Res. 37:1996;209-216.
28. Quirion R., Welner S., Gauthier S., Bedard P. Neurotensin binding sites in monkey and human brains; autoradiographic distribution and effects of MPTP. Synapse. 1:1987;559-566.
29. Sesack S.R., Deutch A.Y., Roth R.H., Bunney B.S. Topographical organization of the efferent projections of the medial prefrontal cortex in the rat: an anterograde tract-tracing study with Phaseolus vulgaris leucoagglutin. J. Comp. Neurol. 290:1989;213-242.
30. Wagstaff J., Bush L., Gibb J.W., Hanson G.R. Endogenous neurotensin antagonizes methamphetamine-enhanced dopaminergic activity. Brain Res. 665:1994;237-244.
31. Wagstaff J., Gibb J.W., Hanson G.R. Role of dopamine D-1 and NMDA receptors in regulating neurotensin release in the striatum and nucleus accumbens. Brain Res. 748:1997;241-244.
32. Wang J.Q., McGinty J.F. The full D-1 dopamine receptor agonist SKF-82958 induces neuropeptide mRNA in the normosensitive striatum of rats: regulation of D-1/D-2 interactions by muscarinic receptors. J. Pharmacol. Exp. Ther. 281:1997;972-982.
33. Wang J.Q., McGinty J.R. Scopolamine augments c-fos and zif/268 messenger RNA expression induced by the full D-1 dopamine receptor agonist SKF 82958 in the intact striatum. Neuroscience. 72:1996;601-616.
34. Yoshikawa K., Williams C., Sabol S.L. Rat brain preproenkephalin mRNA: cDNA cloning, primary structure, and distribution in the central nervous system. J. Biol. Chem. 259:1984;14301-14308.
35. Young W.S. Jr., Bonner T.I., Brann M.R. Mesencephalic dopamine neurons regulate the expression of neuropeptide mRNAs in the rat forebrain. Proc. Natl. Acad. Sci. USA. 83:1986;9827-9831.
36. Zahm D.S., Williams E.S., Krause J.E., Welch M.A., Grosu D.S. Distinct and interactive effects of D-amphetamine and haloperidol on levels of neurotensin and its mRNA in subterritories in the dorsal and ventral striatum of the rat. J. Comp. Neurobiol. 400:1998;487-503.
37. P. Paxinos, C. Watson, The Rat Brain in Stereotaxic Coordinates, Academic Press, New York, 1982.